
At Health Law Alliance, defending pharmacy providers from unwarranted terminations by PBMs isn’t just a part of what we do - it’s what we know best. This month, our attorneys’ tireless advocacy resulted in Optum rescinding its decision to terminate a New York pharmacy. This monumental reversal is just one of a series of victories from our PBM audit team, who specialize in employing strategic, tailored expertise to fight back against the largest PBMs in the nation - and win.
In June 2025, OptumRx moved to terminate a New York pharmacy from its network following a desktop audit, citing noncompliance with Optum’s pharmacy provider manual. Specifically, Optum cited inventory discrepancies and isolated purchases from a non-accredited wholesaler - purchases which accounted for less than 0.3% of the pharmacy’s total claims during the audit period - as grounds for its decision to terminate the pharmacy. The pharmacy, which had served in Optum’s network for over a decade, retained Health Law Alliance to appeal Optum’s termination.
From Termination to Reinstatement: The Legal Strategy That Reversed Optum’s Decision
Having served hundreds of pharmacies across the nation, our team of expert healthcare defense attorneys utilized its tried-and-true strategy for preparing effective PBM audit appeals: leveraging the pharmacy’s dispensing data and inventory purchase histories to create a comprehensive, robust appeal. In the appeal, Health Law Alliance emphasized that Optum’s termination was a disproportionate and draconian response to minor and remediable issues. Optum claimed that termination was warranted based on allegedly “discrepant” claims that comprised less than 1% of Optum’s total reimbursements to the pharmacy in 2024. Further, our attorneys highlighted that in calculating the pharmacy’s inventory, Optum had failed to account for numerous medications that had been purchased prior to the audit period, which Optum summarily ignored without explanation. The appeal emphasized that termination over minor errors, which the pharmacy rectified by implementing comprehensive inventory purchasing protocols tailored to Optum’s concerns, was not only unjustified, but a clear breach of Optum’s legal and contractual obligations.
In August, Optum agreed to rescind its decision to terminate the pharmacy, allowing the pharmacy to remain a provider of Optum’s networks and protecting the pharmacy’s longstanding reputation. Our successful appeal protected the pharmacy from significant financial harm, allowing the pharmacy to continue serving Optum patients with confidence.
Facing Termination? HLA Can Help
Independent pharmacy owners call us every day facing erroneous audit findings and unjust terminations from some of the nation’s most powerful PBMs. At Health Law Alliance, our expert attorneys have years of proven experience protecting pharmacies from PBM overreach. Our recent victory over Optum is just one example of our team’s dedication to ensuring justice is served.
Received a termination notice from a PBM but not sure where to start? That’s where we come in. We’re here to help you navigate the appeal process with confidence. Contact us today.
MORE ARTICLES BY CATEGORY
How Pharmacies Can Challenge Unfair PBM Audit Findings
PBM audits can leave pharmacies facing exaggerated findings, steep recoupments, and even network termination. With the right strategies and legal support, pharmacies can successfully challenge unfair results and protect their business.
Read More >>Top Red Flags That May Trigger a PBM Audit
PBM audits can be disruptive, costly, and often triggered by high prescription volumes, dispensing irregularities, or claim activity. Pharmacies can reduce risks through strong documentation, compliance, and legal support to challenge unfair findings and protect network status.
Read More >>Approaching the Telehealth Policy Cliff: Medicare Telehealth Flexibilities to Expire Next Week
Without further congressional action, COVID-19 era telehealth flexibilities are set to expire on September 30, 2025. Read more to learn about what’s set to change and key guidance for telehealth providers to prepare to adapt to pre-pandemic coverage rules.
Read More >>OIG Doubles Down on Increased Oversight for RPM in New Report
On August 28, 2025, the US Department of Health and Human Services’ Office of the Inspector General published a report outlining billing data trends for remote patient monitoring (RPM) in Medicare, renewing its calls for increased oversight into RPM services. Learn more about the reports key findings.
Read More >>